XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2016/08/31/mylan-files-two-petitions-for-ipr-on-genentechs-herceptin-patent/20%Monthly2018-05-25 17:23
https://www.bigmoleculewatch.com/2016/08/31/drug-costs-study-argues-for-increased-funding-for-biosimilar-review/20%Monthly2018-01-09 17:58
https://www.bigmoleculewatch.com/2016/08/30/breaking-news-fda-approves-sandozs-erelzi-biosimilar-to-enbrel-etanercept/20%Monthly2018-05-25 16:03
https://www.bigmoleculewatch.com/2016/08/29/litigation-update-motions-in-janssen-v-celltrion-for-entry-of-final-judgment-and-case-scheduling/20%Monthly2018-05-25 16:02
https://www.bigmoleculewatch.com/2016/08/26/australia-allows-substitution-of-biosimilar-for-etanercept-brand/20%Monthly2018-01-09 17:56
https://www.bigmoleculewatch.com/2016/08/25/celltrion-files-petition-for-ipr-on-genentechs-rituximab-patent/20%Monthly2018-06-04 15:01
https://www.bigmoleculewatch.com/2016/08/24/whats-in-a-name-a-quick-guide-to-biologic-drug-names/20%Monthly2018-01-09 17:55
https://www.bigmoleculewatch.com/2016/08/23/janssen-v-celltrion-stipulation-of-dismissal/20%Monthly2018-05-25 15:52
https://www.bigmoleculewatch.com/2016/08/23/celltrion-remsima-shipments-begin/20%Monthly2018-05-25 15:51
https://www.bigmoleculewatch.com/2016/08/19/breaking-news-memorandum-order-issued-in-janssen-v-celltrion/20%Monthly2018-05-25 15:50
https://www.bigmoleculewatch.com/2016/08/19/bpcia-litigation-roundup-summer-2016/20%Monthly2018-05-25 15:50
https://www.bigmoleculewatch.com/2016/08/19/ipr-petition-filed-on-genentech-patent-directed-to-method-of-producing-polypeptides/20%Monthly2018-01-09 17:52
https://www.bigmoleculewatch.com/2016/08/18/dct-invalidates-janssens-remicade-patent-on-sj/20%Monthly2018-05-25 15:47
https://www.bigmoleculewatch.com/2016/08/17/survey-suggests-pharmacists-prefer-non-proprietary-proper-names-for-biosimilars/20%Monthly2016-08-17 20:17
https://www.bigmoleculewatch.com/2016/08/17/biosimilars-development-updates-2/20%Monthly2018-01-09 17:51
https://www.bigmoleculewatch.com/2016/08/16/celltrion-files-petition-for-ipr-on-biogens-rituximab-patent/20%Monthly2018-01-09 17:49
https://www.bigmoleculewatch.com/2016/08/16/amgen-v-hospira-amgens-appeal-to-the-fed-cir-will-proceed-on-the-merits/20%Monthly2018-05-25 15:45
https://www.bigmoleculewatch.com/2016/08/15/federal-circuit-to-review-ipr-claim-amendment-rules-en-banc/20%Monthly2017-05-15 20:55
https://www.bigmoleculewatch.com/2016/08/12/apotex-files-petition-for-ipr-on-amgens-neulasta-patent/20%Monthly2018-01-09 17:29
https://www.bigmoleculewatch.com/2016/08/12/bpcia-litigation-updates-amgen-v-apotex-immunex-v-sandoz-janssen-v-celltrion/20%Monthly2018-05-25 15:44
https://www.bigmoleculewatch.com/2016/08/12/tnf-alpha-biosimilars-are-as-safe-as-branded-counterparts/20%Monthly2016-08-13 00:01
https://www.bigmoleculewatch.com/2016/08/11/update-janssen-v-hyclone-hyclone-files-a-motion-for-injunctive-relief-to-dismiss-and-to-stay/20%Monthly2018-06-04 14:20
https://www.bigmoleculewatch.com/2016/08/10/update-amgen-v-apotex-amgen-argues-they-have-met-their-burden-to-prove-infringement/20%Monthly2018-05-25 15:43
https://www.bigmoleculewatch.com/2016/08/10/coherus-submits-351k-bla-application-to-fda-for-pegfilgrastim-biosimilar/20%Monthly2018-01-09 17:11
https://www.bigmoleculewatch.com/2016/08/09/ema-accepts-mylan-and-biocons-application-for-authorization-to-market-a-pegfilgrastim-biosimilar/20%Monthly2018-01-09 17:10
https://www.bigmoleculewatch.com/2016/08/08/fda-accepts-mercks-lantus-biosimilar-for-review/20%Monthly2018-01-09 17:09
https://www.bigmoleculewatch.com/2016/08/08/abbvie-sues-amgen-to-prevent-launch-of-humira-biosimilar/20%Monthly2018-01-09 17:07
https://www.bigmoleculewatch.com/2016/08/05/big-molecule-watch-page-devoted-to-tracking-iprs-on-biologic-products/20%Monthly2016-08-23 19:00
https://www.bigmoleculewatch.com/2016/08/05/court-denies-hospiras-motion-to-dismiss-bpcia-notice-claims-in-amgen-v-hospira/20%Monthly2018-05-25 15:41
https://www.bigmoleculewatch.com/2016/08/05/abbvie-files-complaint-against-amgen/20%Monthly2018-05-25 15:41
https://www.bigmoleculewatch.com/2016/08/03/cvs-to-replace-two-brand-name-biologics-with-follow-onbiosimilar-products-in-2017/20%Monthly2018-01-09 16:58
https://www.bigmoleculewatch.com/2016/08/02/archigen-rituximab-phase-i-trials/20%Monthly2018-01-09 16:57
https://www.bigmoleculewatch.com/2016/08/01/amgens-appeal-of-district-court-discovery-rulings-in-amgen-v-hospira/20%Monthly2018-05-25 15:40